BORA PHARMACEUTICALS LTD (6472) — Free Cash Flow Generation Index
BORA PHARMACEUTICALS LTD (6472) has a Free Cash Flow Generation Index of 0.63x as of March 2026. Free cash flow of NT$357.38 Million represents 1% of operating cash flow (NT$568.46 Million). Read 6472 total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
BORA PHARMACEUTICALS LTD Free Cash Flow Generation Index (2019–2025)
Historical FCF Generation Index trend for BORA PHARMACEUTICALS LTD across 7 annual periods. Explore 6472 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for BORA PHARMACEUTICALS LTD (2019–2025)
Year-by-year Free Cash Flow Generation Index for BORA PHARMACEUTICALS LTD. For the full company profile including market capitalisation, see BORA PHARMACEUTICALS LTD (6472) market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | NT$3.31 Billion | NT$4.24 Billion | NT$928.67 Million | ▲ +160.8% |
| 2024 | 0.30x | NT$293.76 Million | NT$980.81 Million | NT$687.05 Million | ▼ -56.6% |
| 2023 | 0.69x | NT$3.18 Billion | NT$4.61 Billion | NT$1.43 Billion | ▼ -23.4% |
| 2022 | 0.90x | NT$1.81 Billion | NT$2.01 Billion | NT$200.22 Million | ▲ +27.5% |
| 2021 | 0.71x | NT$873.05 Million | NT$1.24 Billion | NT$363.58 Million | ▲ +388.4% |
| 2020 | 0.14x | NT$25.70 Million | NT$177.79 Million | NT$152.09 Million | ▲ +107.2% |
| 2019 | -2.01x | NT$-465.56 Million | NT$231.77 Million | NT$697.33 Million | — |